Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results...
Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results from clinical tests of its cholesterol-reducing treatment. The firm says it will continue the study with increased dosages.
From other sites
at Nasdaq.com (Wed, 12:15PM)
at Zacks.com (Mar 13, 2015)
at Benzinga.com (Feb 27, 2015)
at Nasdaq.com (Jan 23, 2015)
at Benzinga.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs